Renier C. Heijkants

Biochemistry, Genetics and Molecular Biology · Life Sciences

7h-index287citations19works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

TGF-β signaling in diseases(8), Cancer, Hypoxia, and Metabolism(7), Ocular Oncology and Treatments(7), Angiogenesis and VEGF in Cancer(4), Melanoma and MAPK Pathways(3)

Publications19 total

Supplementary figure legends from Activin Receptor-like Kinase 1 Ligand Trap Reduces Microvascular Density and Improves Chemotherapy Efficiency to Various Solid Tumors
2023Open Access
Supplementary Figures from Activin Receptor-like Kinase 1 Ligand Trap Reduces Microvascular Density and Improves Chemotherapy Efficiency to Various Solid Tumors
2023Open Access
Data from Activin Receptor-like Kinase 1 Ligand Trap Reduces Microvascular Density and Improves Chemotherapy Efficiency to Various Solid Tumors
2023Open Access
Data from Activin Receptor-like Kinase 1 Ligand Trap Reduces Microvascular Density and Improves Chemotherapy Efficiency to Various Solid Tumors
2023Open Access
Supplementary Figures from Activin Receptor-like Kinase 1 Ligand Trap Reduces Microvascular Density and Improves Chemotherapy Efficiency to Various Solid Tumors
2023Open Access
Supplementary figure legends from Activin Receptor-like Kinase 1 Ligand Trap Reduces Microvascular Density and Improves Chemotherapy Efficiency to Various Solid Tumors
2023Open Access
MDMX Regulates Transcriptional Activity of p53 and FOXO Proteins to Stimulate Proliferation of Melanoma Cells
Cancers·2022· 9 citedOpen Access
Selective PKCδ Inhibitor B106 Elicits Uveal Melanoma Growth Inhibitory Effects Independent of Activated PKC Isoforms
ACS Chemical Biology·2018· 7 citedOpen Access
Novel functions of MDMX and innovative therapeutic strategies for melanoma
Data Archiving and Networked Services (DANS)·2018Open Access
Overexpression of EZH2 in conjunctival melanoma offers a new therapeutic target
The Journal of Pathology·2018· 27 citedOpen Access
Targeting MDMX and PKCδ to improve current uveal melanoma therapeutic strategies
Oncogenesis·2018· 15 citedOpen Access
Combined inhibition of CDK and HDAC as a promising therapeutic strategy for both cutaneous and uveal metastatic melanoma
Oncotarget·2017· 39 citedOpen Access
Targeting of the MAPK and AKT pathways in conjunctival melanoma shows potential synergy
Data Archiving and Networked Services (DANS)·2016· 2 cited
Targeting of the MAPK and AKT pathways in conjunctival melanoma shows potential synergy
Oncotarget·2016· 61 citedOpen Access
Combined CDK and HDAC inhibition induces apoptosis in both uveal and cutaneous melanoma
European Journal of Cancer·2016
Endoglin targeting inhibits tumor angiogenesis and metastatic spread in breast cancer
Oncogene·2016· 72 citedOpen Access
Activin Receptor-like Kinase 1 Ligand Trap Reduces Microvascular Density and Improves Chemotherapy Efficiency to Various Solid Tumors
Clinical Cancer Research·2015· 54 citedOpen Access
Abstract 1370: Activin receptor-like kinase 1 ligand trap reduces microvascular density and improves chemotherapy efficiency to various solid tumors
Cancer Research·2015· 1 cited
Abstract 4130: Dual targeting of VEGF and endoglin inhibits tumor angiogenesis and metastatic spread
Cancer Research·2015

Frequent Co-authors

Lukas J.A.C. Hawinkels(11), Madelon Paauwe(10), Aart G. Jochemsen(8), Amaya García de Vinuesa(8), Marianna Kruithof‐de Julio(8), Marie‐José Goumans(8), Peter ten Dijke(8), Eliza Wiercinska(7), Evangelia Pardali(7), Laura Mezzanotte(7), Stijn Keereweer(7), Tanya M. Braumuller(7), Jos Jonkers(7), Clemens W.G.M. Löwik(7), Timo L.M. ten Hagen(7), Amina F.A.S. Teunisse(6), Martine J. Jager(3), Robert M. Verdijk(3), Maaike Nieveen(3), Gabi W. van Pelt(2)